Insider track record Other Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Diana Conrad. Director active across 1 company, notably GSK plc. Cumulatively, 52 filings have been logged. History available since 12 October 2023. The latest transaction was disclosed on 14 April 2026 (Vesting). Regulator: RNS (LSE). The full history is openly available.
Declarations 52 total
● Chief People Officer · Executives · 14 Apr 2026 · GSK plc 598 shares @ £21.67 0.0000% mcap 0.2% of flow GB00BN7SWP63⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-2 ● Chief People Officer · Executives · 9 Apr 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-6 Ideal exit: 4 Jan 2027 (T+270) ● Chief People Officer · Executives · 9 Apr 2026 · GSK plc 5 shares @ £21.338 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-2 Ideal exit: 4 Jan 2027 (T+270) ● Chief People Officer · Executives · 13 Feb 2026 · GSK plc 102,653 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-4 ● Chief People Officer · Executives · 13 Feb 2026 · GSK plc 54,951 shares @ £21.6002 13.8% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-5 ● Chief People Officer · Executives · 12 Feb 2026 · GSK plc 15,984 shares @ £21.50 4.0% of flow GB00BN7SWP63⌘ RNS:6207777f-2477-470b-868f-21f92714189a-2 ● Chief People Officer · Executives · 9 Feb 2026 · GSK plc 25,742 shares 0
GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-2 ● Chief People Officer · Executives · 9 Feb 2026 · GSK plc 13,801 shares @ £22.0162 3.5% of flow GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-3 ● Chief People Officer · Executives · 8 Jan 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-11 Ideal exit: 5 Oct 2026 (T+270) ● Chief People Officer · Executives · 8 Jan 2026 · GSK plc 4 shares @ £18.9425 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-2 Ideal exit: 5 Oct 2026 (T+270) ● Chief People Officer · Executives · 9 Jan 2026 · GSK plc 686 shares @ £18.91 0.2% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-26 ● Chief People Officer · Executives · 10 Oct 2025 · GSK plc 784 shares @ £16.40 0.2% of flow GB00BN7SWP63⌘ RNS:5862277-2 ● Chief People Officer · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-14 Ideal exit: 6 Jul 2026 (T+270) ● Chief People Officer · Executives · 9 Oct 2025 · GSK plc 5 shares @ £16.392 0.0% of flow GB00BN7SWP63⌘ RNS:5859068-1 Ideal exit: 6 Jul 2026 (T+270) ● Chief People Officer · Executives · 11 Jul 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5739159-5 Ideal exit: 7 Apr 2026 (T+270) ● Chief People Officer · Executives · 10 Jul 2025 · GSK plc 874 shares @ £14.545 0.2% of flow GB00BN7SWP63⌘ RNS:5737340-21 ● Chief People Officer · Executives · 10 Jul 2025 · GSK plc 5 shares @ £14.444 0.0% of flow GB00BN7SWP63⌘ RNS:5737340-10 Ideal exit: 6 Apr 2026 (T+270) ● Chief People Officer · Executives · 16 Apr 2025 · GSK plc 985 shares @ £12.75 0.2% of flow GB00BN7SWP63⌘ RNS:5622701-2 ● Chief People Officer · Executives · 10 Apr 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5617047-9 Ideal exit: 5 Jan 2026 (T+270) ● Chief People Officer · Executives · 10 Apr 2025 · GSK plc 7 shares @ £13.1271 0.0% of flow GB00BN7SWP63⌘ RNS:5615070-10 Ideal exit: 5 Jan 2026 (T+270) ● Chief People Officer · Executives · 17 Feb 2025 · GSK plc 112,442 shares @ £14.35 25.1% of flow GB00BN7SWP63⌘ RNS:5546836-2 ● Chief People Officer · Executives · 17 Feb 2025 · GSK plc 15,257 shares @ £14.35 3.4% of flow GB00BN7SWP63⌘ RNS:5546650-2 ● Chief People Officer · Executives · 18 Feb 2025 · GSK plc 88,027 shares 0
GB00BN7SWP63⌘ RNS:5546637-1 ● Chief People Officer · Executives · 18 Feb 2025 · GSK plc 47,121 shares @ £14.2531 10.5% of flow GB00BN7SWP63⌘ RNS:5546637-2 ● Chief People Officer · Executives · 17 Feb 2025 · GSK plc 12,825 shares 0
GB00BN7SWP63⌘ RNS:5546603-4 25 of 52 declarations
Load more (27 remaining) About Diana Conrad Diana Conrad is a declarant who has made 52 filings in total. In her most recent filings, she made a purchase totaling 994 EUR and sales totaling 4,498,499 EUR. The first filing was made on October 13, 2023, and the last is scheduled for April 16, 2026. Among her notable filings, there is a sale of 1,361,861.88 EUR on February 17, 2026, and a purchase of 1,935,686.58 EUR on February 21, 2025.